Angiotensin-receptor blockers and cancer: urgent regulatory review needed

被引：15

|

作者：

Nissen, Steven E. ^{[1
]}

机构：

[1] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA

来源：

LANCET ONCOLOGY | 2010年 / 11卷 / 07期

关键词：

RISK;

D O I：

10.1016/S1470-2045(10)70142-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：605 / 606

页数：2

相关论文

共 50 条

[1] Angiotensin-receptor blockers for prehypertension
Vidt, Donald G.
CURRENT HYPERTENSION REPORTS, 2006, 8 (05) : 361 - 362
[2] Angiotensin-receptor blockers for prehypertension
Carl, Dan
Sica, Domenic A.
CURRENT HYPERTENSION REPORTS, 2006, 8 (04) : 307 - 308
[3] Review: Angiotensin-receptor blockers increase risk for cancer but not cancer-related death
Vavalle, John P.
Newby, L. Kristin
ANNALS OF INTERNAL MEDICINE, 2010, 153 (12)
[4] Angiotensin-receptor blockers: Another victory
Sica, DA
CURRENT HYPERTENSION REPORTS, 2002, 4 (04) : 321 - 323
[5] Angiotensin-receptor blockers: Another victory
Domenic A. Sica
Current Hypertension Reports, 2002, 4 : 321 - 323
[6] The metabolic effects of angiotensin-receptor blockers
Michael L. Tuck
Dalila B. Corry
Current Hypertension Reports, 2005, 7 : 85 - 87
[7] The metabolic effects of angiotensin-receptor blockers
Tuck, ML
Corry, DB
CURRENT HYPERTENSION REPORTS, 2005, 7 (02) : 85 - 87
[8] Review: Angiotensin-receptor blockers do not increase adverse cardiovascular outcomes
Halim, Sharif A.
Newby, L. Kristin
ANNALS OF INTERNAL MEDICINE, 2011, 155 (04)
[9] Angiotensin-receptor blockers and diuretics - Advantages of combination
Mimran, A
Weir, MR
BLOOD PRESSURE, 2005, 14 (01) : 6 - 11
[10] VALIDD should not invalidate angiotensin-receptor blockers
Ahmed, Ali
Perry, Gilbert J.
Husain, Ahsan
LANCET, 2007, 369 (9579): : 2053 - 2054

← 1 2 3 4 5 →